Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes (ICARUS): A Phase I Dose-escalation Radiosurgery Study in Metastatic Cancers
Latest Information Update: 20 May 2024
At a glance
- Drugs Atezolizumab (Primary)
- Indications Cancer; Colorectal cancer; Head and neck cancer; Lung cancer; Ovarian cancer; Sarcoma
- Focus Adverse reactions
Most Recent Events
- 20 May 2024 New trial record